All About Multiple Sclerosis

More MS news articles for April 2004

Serono study says Rebif drug can reduce brain lesions

http://cbs.marketwatch.com/news/newsfinder/pulseone.asp?dateid=38105.1099305556-814050271&siteid=google&dist=google

April 28, 2004
Steve Goldstein
CBS MarketWatch

Swiss biotech Serono (SRA) on Wednesday said a study said its Rebif drug can reduce the long-term accumulation of brain lesion volume in remitting multiple sclerosis drug. The study was presented at the annual American Academy of Neurology meeting.

Copyright © 2004, MarketWatch